Q2 EPS Estimates for Beta Bionics Lifted by Leerink Partnrs
Beta Bionics, Inc. (NASDAQ:BBNX – Free Report) – Equities research analysts at Leerink Partnrs raised their Q2 2025 EPS estimates for shares of Beta Bionics in a report released on Tuesday, May 6th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings per share of ($0.46) for the quarter, up from […]
